Skip to main content
logo
Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
39.80
-0.45 (-1.12%)
At close: Jul 2, 2026, 4:00 PM EDT
40.59
+0.79 (1.98%)
After-hours: Jul 2, 2026, 6:16 PM EDT

Indivior Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2911,2391,1881,093901791
Revenue Growth (YoY)
10.34%4.29%8.69%21.31%13.91%22.26%
Cost of Revenue
-242-246-231-174-151127
Gross Profit
1,049994957919749664
Selling, General & Admin
-626-634-612-565-469431
Research & Development
-37----52
Other Operating Expenses
26192410304-32
Total Operating Expenses
-661-628-420-155-165451
Operating Income
33326238-152-81213
Interest Income
21222343-194
Interest Expense
-40-45-41-3527-27
Total Non-Operating Income (Expense)
-19-23-1888-23
Pretax Income
29523920-145-89190
Provision for Income Taxes
-18-29-1319-44-15
Net Income
31326833-164-45205
Net Income to Common
2512107-126-44205
Net Income Growth
-2900.00%----
Shares Outstanding (Basic)
252526272829
Shares Outstanding (Diluted)
262627272830
Shares Change (YoY)
-1.17%-3.76%-2.92%-1.44%-8.52%0.84%
EPS (Basic)
10.108.400.25-4.60-1.607.05
EPS (Diluted)
9.758.200.25-4.60-1.606.75
EPS Growth
-3180.00%----
Free Cash Flow
-192-937-308-9349
Free Cash Flow Per Share
-7.46-3.630.26-11.24-0.3211.48
Gross Margin
81.25%80.23%80.56%84.08%83.13%83.94%
Operating Margin
25.79%21.15%3.20%-13.91%-8.99%26.93%
Profit Margin
24.24%21.63%2.78%-15.00%-4.99%25.92%
FCF Margin
-14.87%-7.51%0.59%-28.18%-1.00%44.12%
EBITDA
35028266-137-65235
EBITDA Margin
27.11%22.76%5.56%-12.53%-7.21%29.71%
EBIT
33326238-152-81213
EBIT Margin
25.79%21.15%3.20%-13.91%-8.99%26.93%
Effective Tax Rate
-6.10%-12.13%-65.00%-13.10%49.44%-7.89%
SEC Filings: 10-K · 10-Q